openPR Logo
Press release

Chemiluminescence Immunoassay Market Future Scope, Size, Share, Growing Trends, Opportunities, Key Segments And Forecast To 2028

12-12-2024 11:02 PM CET | Health & Medicine

Press release from: ABNewswire

The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Siemens Healthineers AG (Germany), DiaSorin S.p.A. (Italy)

The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Siemens Healthineers AG (Germany), DiaSorin S.p.A. (Italy)

Browse 181 market data Tables and 52 Figures spread through 283 Pages and in-depth TOC on "Chemiluminescence Immunoassay Market by Product (Instrument, Consumable), Technology (Chemiluminescence Enzyme, Microparticle Chemiluminescence), Sample (Blood, Urine), Application (Infectious Disease, Oncology), End User - Global Forecast to 2028
Chemiluminescence Immunoassay Market [https://www.marketsandmarkets.com/Market-Reports/chemiluminescence-immunoassay-clia-market-131865271.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $13.2 billion in 2023 and is poised to reach $19.0 billion by 2028, growing at a CAGR of 7.5% from 2023 to 2028 according to a new report by MarketsandMarkets Trademark . Growth in the chemiluminescence immunoassay market is mainly driven by the growing prevalence of chronic diseases, Advancements in improving chemiluminescence immunoassay technologies in recent years, rising demand for point-of-care testing (POCT), growth of biotechnology and biopharmaceutical industries, and a rapid increase in geriatric population globally. In addition, emerging markets such as India and China are expected to offer growth opportunities for players operating in the chemiluminescence immunoassay market during the forecast period. However, the high cost of CLIA systems is restricting the growth of this market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131865271 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131865271&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

the consumables segment held the largest share of the chemiluminescence market, by product segment

Based on product, the global chemiluminescence immunoassay market is categorized into consumables and instruments. The repetitive purchase of consumables such as reagents for every test is a major factor driving the growth of the segment. Besides the availability of efficient assays and reagents for diagnostic purposes has propelled its demand among end users.

In 2022, the infectious disease diagnostics segment held the largest share of the chemiluminescence market, by application segment

The chemiluminescence immunoassay market, by application, has been segmented into infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, blood screening, autoimmune disorders, allergy diagnostics, toxicology, newborn screening, gastroenterology, neurology, respiratory, therapeutic drug monitoring, metabolic disorders, and other applications. The large share of this segment can be attributed to the development and introduction of advanced assays for the diagnosis of different diseases & conditions, and the increase in the population with infectious diseases.

North America dominates the global chemiluminescence immunoassay market

Based on the region, the chemiluminescence immunoassay market is segmented into North America, Europe, Asia Pacific, and Rest of the world. In 2022, North America accounted for the largest share of the chemiluminescence immunoassay market. The large share of North America in this market can be attributed to the increasing prevalence of infectious diseases and cancer and rising healthcare spending, which is highly developed in the US and Canada.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=131865271 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=131865271&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

Chemiluminescence Immunoassay Market Dynamics:

Drivers:

1. Rising incidence of chronic and infectious diseases across the globe

Restraints:

1. High cost of CLIA related products

Opportunities:

1. Increasing number of collaborations and partnerships in the CLIA market

Challenges:

1. Lack of skilled professionals and aging workforce

Key Market Players:

The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Siemens Healthineers AG (Germany), DiaSorin S.p.A. (Italy), Abbott Laboratories (US), Shenzhen Mindray Bio-medical Electronics Co., Ltd. (China), Sysmex Corporation (Japan), Diatron (Hungary), Getein Biotech, Inc. (China), Werfen (Spain), QuidelOrtho Corporation (US), EUROIMMUN (Germany), Merck KGaA (Germany), Tosoh Corporation (Japan), Trivitron Healthcare (India), Abnova Corporation (Taiwan), Elabscience (US), Maccura Biotechnology Co., Ltd. (China), Autobio Diagnostics Co., Ltd. (China), Jiangsu Zecen Biotech Co., Ltd (China), Rayto Life and Analytical Sciences Co., Ltd. (China), Daan Gene Co., Ltd. (China), DYNEX TECHNOLOGIES, Inc. (US), Zybio, Inc. (China), Wiener Laboratorios SAIC (Argentina), Tianjin Era Biology Technology Co., Ltd. (China).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=131865271 [https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=131865271&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

Chemiluminescence Immunoassay Market Advantages:

* Sensitivity and Specificity: Chemiluminescence immunoassays provide high sensitivity and specificity in detecting target molecules. The use of specific antibodies and the amplification of chemiluminescent signals result in low detection limits and minimal interference from background noise, ensuring accurate and reliable results.
* Wide Analyte Range: Chemiluminescence immunoassays can detect a diverse range of analytes, including proteins, hormones, tumor markers, infectious agents, and drugs. This versatility allows for comprehensive testing across various applications, including clinical diagnostics, pharmaceutical research, environmental monitoring, and food safety.
* Multiplexing Capabilities: Chemiluminescence immunoassays enable multiplexing, the simultaneous detection of multiple analytes in a single assay. This capability is particularly valuable in clinical diagnostics, where it allows for the efficient and cost-effective assessment of multiple biomarkers, aiding in disease diagnosis, prognosis, and treatment monitoring.
* Speed and Automation: Chemiluminescence immunoassays offer rapid results due to the short incubation times required for chemiluminescent reactions. Additionally, the integration of automated systems and robotic platforms streamlines the workflow, reducing manual handling and increasing throughput. This combination of speed and automation enhances laboratory efficiency and productivity.
* Long-Term Stability: Chemiluminescent reagents used in immunoassays generally exhibit excellent stability, allowing for longer shelf life and consistent performance over time. This stability contributes to cost savings and minimizes the need for frequent reagent replacements.
* Point-of-Care Applications: Chemiluminescence immunoassays are well-suited for point-of-care testing due to their rapid turnaround time, ease of use, and portability. This enables healthcare professionals to obtain timely diagnostic information at the patient's location, leading to improved patient management, treatment decisions, and disease control.
* Clinical Significance: Chemiluminescence immunoassays play a crucial role in clinical diagnostics by aiding in the early detection and monitoring of diseases. Their accuracy and reliability support clinicians in making informed decisions regarding patient care, contributing to improved health outcomes.
* Research Advancements: In the research field, chemiluminescence immunoassays provide valuable tools for studying biomarkers, elucidating disease mechanisms, and developing new therapeutics. Their high sensitivity and multiplexing capabilities enable researchers to explore complex biological processes, accelerating scientific discoveries and advancements.

Overall, the advantages of the chemiluminescence immunoassay market lie in its sensitivity, specificity, wide analyte range, multiplexing capabilities, speed, automation, stability, point-of-care applications, clinical significance, and impact on research. These advantages position chemiluminescence immunoassays as a prominent technology in diagnostics and research, with the potential to revolutionize healthcare and scientific understanding in the coming years.

High-Throughput Screening Market - Report Objectives:

* To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
* To define, describe, segment, and forecast the chemiluminescence immunoassay market by product, technology, sample type, application, end user, and region
* To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
* To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall chemiluminescence immunoassay market
* To forecast the size of the chemiluminescence immunoassay market in four main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific and Rest of the world
* To profile key players in the chemiluminescence immunoassay market and comprehensively analyze their core competencies and market shares
* To track and analyze competitive developments, such as product launches and approvals; expansions; collaborations, and agreements, & partnerships; of the leading players in the chemiluminescence immunoassay market
* To benchmark players within the chemiluminescence immunoassay market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=chemiluminescence-immunoassay-market-future-scope-size-share-growing-trends-opportunities-key-segments-and-forecast-to-2028]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/chemiluminescence-immunoassay-clia-market-131865271.html



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chemiluminescence Immunoassay Market Future Scope, Size, Share, Growing Trends, Opportunities, Key Segments And Forecast To 2028 here

News-ID: 3785934 • Views:

More Releases from ABNewswire

Myocardial Infarction Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approval by DelveInsight | Faraday Pharma, Acticor Biotech, Boehringer Ingelheim, NuvOx Pharma
Myocardial Infarction Pipeline 2025: Therapies Under Investigation, Clinical Tri …
Myocardial Infarction pipeline constitutes 30+ key companies continuously working towards developing 40+ Myocardial Infarction treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Myocardial Infarction Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/myocardial-infarction-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Myocardial Infarction Market. The Myocardial Infarction Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products
AV Access Launches AnyCo A6: A Scalable USB & Bluetooth Speakerphone for Crystal-Clear Audio in Large Meeting Rooms
AV Access Launches AnyCo A6: A Scalable USB & Bluetooth Speakerphone for Crystal …
AV Access introduces the AnyCo A6, a high-performance USB and Bluetooth speakerphone with daisy-chain capability, designed to deliver exceptional audio coverage in large meeting spaces. With support for up to 9 units in cascade, intelligent noise cancellation, and seamless integration with the eShare W90 wireless conferencing system, the AnyCo A6 is ideal for hybrid meetings and enterprise collaboration. AV Access, a leading provider of Pro AV and AV over IP solutions,
NK Cell Therapy Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Amgen, ImmunityBio, Dragonfly Therapeutics, Glycostem Therapeutics, Athenex
NK Cell Therapy Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, NK Cell Therapy pipeline constitutes 140+ key companies continuously working towards developing 160+ Nk Cell Therapy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Nk Cell Therapy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also
SBoM Shop Launches as First Softball-Exclusive Apparel Brand Designed by and for the Softball Community
SBoM Shop Launches as First Softball-Exclusive Apparel Brand Designed by and for …
New apparel brand SBoM Shop fills a unique market gap by creating softball-specific clothing that celebrates the sport's culture through empowering designs. Founded in 2024, the home-based business has rapidly expanded online while partnering with local leagues and supporting youth softball programs nationwide. SBoM Shop has emerged as the first apparel brand exclusively dedicated to softball culture, addressing a long-overlooked market need for sport-specific clothing that authentically represents the passion, humor,

All 5 Releases


More Releases for Chemiluminescence

Rising Chronic Diseases Fuels Chemiluminescence Immunoassay Analyzer Market Grow …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Chemiluminescence Immunoassay Analyzer Market Through 2025? There has been significant growth in the chemiluminescence immunoassay analyzer market recently. It is expected to rise from its current value of $5.67 billion in 2024 to $6.03 billion in 2025, experiencing a compound annual growth
Rising Chronic Diseases Fuels Chemiluminescence Immunoassay Analyzer Market Grow …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Chemiluminescence Immunoassay Analyzer Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size of the chemiluminescence immunoassay analyzer has seen significant growth in the past few years. It is expected to rise from $5.67 billion in 2024 to $6.08 billion in 2025, with a
Rising Chronic Diseases Fuels Chemiluminescence Immunoassay Analyzer Market Grow …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Chemiluminescence Immunoassay Analyzer Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size of the chemiluminescence immunoassay analyzer has seen significant growth in the past few years. It is expected to rise from $5.67 billion in 2024 to $6.08 billion in 2025, with a
Rising Chronic Diseases Fuels Chemiluminescence Immunoassay Analyzer Market Grow …
The Chemiluminescence Immunoassay Analyzer Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Chemiluminescence Immunoassay Analyzer Market Size During the Forecast Period? The chemiluminescence immunoassay analyzer market size has grown strongly in recent years. It will grow from $5.67 billion in 2024 to
Prominent Chemiluminescence Immunoassay Analyzer Market Trend for 2025: Innovati …
What combination of drivers is leading to accelerated growth in the chemiluminescence immunoassay analyzer market? The increasing incidence of chronic illnesses is predicted to spur the expansion of the chemiluminescence immunoassay analyzer market. Factors like aging populations, unhealthy lifestyles, and advancements in healthcare which prolong the lifespan of individuals with severe conditions, contribute to the rise in chronic diseases. Chemiluminescence immunoassay analyzers play a crucial role in managing chronic illnesses by
Chemiluminescence Immunoassay Market worth $19.0 billion |
Chemiluminescence Immunoassay Market in terms of revenue was estimated to be worth $13.2 billion in 2023 and is poised to reach $19.0 billion by 2028, growing at a CAGR of 7.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. Growth in the chemiluminescence immunoassay market is mainly driven by the growing prevalence of chronic diseases, Advancements in improving chemiluminescence immunoassay technologies in recent years, rising demand for